About
Plasma fractions, anti-spasmodic drug
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalJapan
Clinical Trials (19)
View allTotal Trials
19
As Lead Sponsor
19
As Collaborator
0
Total Enrollment
1,849
By Phase
PHASE3: 14PHASE2: 4PHASE1/PHASE2: 1
By Status
COMPLETED: 18UNKNOWN: 1
Clinical Trials Pipeline19 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05177939Lead Sponsor
Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis
PHASE3Unknown
40 participants
Started: Mar 3, 2022 · Completed: Oct 31, 2024
NCT04097574Lead Sponsor
Study of NPO-13 During Colonoscopy
PHASE2Completed
158 participants
Started: Aug 26, 2019 · Completed: Mar 26, 2020
NCT03794310Lead Sponsor
Study of NPF-08 in Patients Who Receive Colonoscopy
PHASE3Completed
632 participants
Started: Jan 5, 2019 · Completed: Jun 19, 2019
NCT03423771Lead Sponsor
Phase I/II Clinical Trial of NPF-08 in Healthy Volunteers
PHASE1/PHASE2Completed
90 participants
Started: Oct 6, 2017 · Completed: Feb 28, 2018
NCT03263910Lead Sponsor
Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy
PHASE3Completed
220 participants
Started: Aug 21, 2017 · Completed: Aug 17, 2018
Locations (1)
Headquarters
Osaka, Japan
Map
Loading map...